Document:

EX-10.2(B)

 Exhibit 10.2(B) 

LEASE TERMINATION AGREEMENT AND RELEASE 

THIS LEASE TERMINATION AGREEMENT AND RELEASE (the “Agreement”) is made this 5th day of May, 2017, by and between G&I
VII ENCINO TRACE II LP, a Delaware limited partnership with an address of 555 East Lancaster Avenue, Suite 100, Radnor, Pennsylvania 19087 (“Landlord”), and MIRNA THERAPEUTICS, INC., a Delaware corporation with an address of
5707 Southwest Parkway, Building II, Suite 100, Austin, Texas 78735 (“Tenant”). 
 WITNESSETH THAT 

WHEREAS, Landlord and Tenant entered into a certain lease dated June 24, 2016 (the “Lease”) for the rental of certain
property consisting of approximately 23,578 square feet of commercial space known as Suite 100 in the building located at 5707 Southwest Parkway, Building II, Austin, Texas 78735, as more particularly described in the Lease (the
“Premises”); and 
 WHEREAS, Landlord and Tenant have agreed to terminate the Lease upon the terms and conditions
set forth herein. 
 NOW, THEREFORE, in consideration of the foregoing and of the mutual promises hereinafter contained and
other valuable consideration the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby agree as follows: 

1. Recitals. The foregoing recitals are true and correct and incorporated herein by reference. All capitalized terms not defined
in this Agreement shall have the meanings ascribed to them in the Lease. 
 2. Lease Termination. Provided the contingency
identified in Section 4 below has occurred and the payment identified in Section 3 below has been received by Landlord, the Lease shall be deemed terminated effective 5:00 p.m. on the date on which Landlord and ARM execute a lease for the
Premises (the “Termination Date”). Tenant hereby waives any right of redemption or other right to reclaim possession of the Premises. Tenant shall also surrender all keys to the Premises to Landlord on or before the Termination Date.
Tenant shall continue to perform all of its obligations under the Lease through the Termination Date. Within five (5) business days after the Termination Date, Landlord will release the Letter of Credit to Tenant and refund the Security
Deposit to Tenant. 

 3. Settlement. In consideration of Landlord’s agreement to execute this
Agreement, Tenant has agreed to pay and Landlord has agreed to accept the sum of Three Million Eight Hundred Seventeen Thousand Five Hundred Twenty-Eight Dollars ($3,817,528.00) (the “Settlement Amount”). The Settlement Amount must be
received by Landlord within three (3) business days following full execution of this Agreement, via wire transfer, pursuant to the wire instructions below: 
  

							
	ACH Instructions:	  		  	[###]	  	
	Account #	  		  	[###]	  	
	ABA/Routing #	  		  	[###]	  	

 TENANT ACKNOWLEDGES AND AGREES THAT TIME IS OF THE ESSENCE WITH RESPECT TO THE PAYMENT DUE TO LANDLORD PURSUANT TO THIS
SECTION 3. 
 4. Contingency. This Agreement is contingent upon Landlord’s execution of a new lease for the Premises with
ARM Holdings (“ARM”). Within three (3) business days after execution of a lease with ARM, Landlord will provide Tenant with written notice thereof. In the event Landlord does not execute a new lease for the Premises with ARM on or
before May 30, 2017 (the “Contingency Date”), Landlord, at its sole option, may extend the Contingency Date for a period of up to sixty (60) days upon written notice to Tenant. If Landlord does not elect to extend the Contingency
Date, this Agreement (including each of the releases set forth herein, but excluding the provisions of Section 12 below, which shall remain in full force and effect) shall be null and void, (i) within three (3) business days after the
Contingency Date, Landlord shall reimburse Tenant for the full Settlement Amount via wire transfer, pursuant to the wire instructions below, and (ii) Landlord and Tenant shall remain fully obligated to perform all of their respective
obligations under the Lease. 
  

							
	Beneficiary Name:	  	Mirna Therapeutics Inc.	  		  	
	Address:	  	2150 Woodward St, Suite 100	  		  	
		  	Austin, TX 78744	  		  	
				
	Routing Number:	  	[###]	  		  	
	Account Number:	  	[###]	  		  	
				
	Bank Name:	  	Comerica Bank	  		  	
	Address:	  	300 W. Sixth St, Suite 2250	  		  	
		  	Austin, TX 78701	  		  	
		  		  		  	

  
  
  

 
  
  

 

 LANDLORD ACKNOWLEDGES AND AGREES THAT TIME IS OF THE ESSENCE WITH RESPECT TO THE REIMBURSEMENT DUE TO TENANT
PURSUANT TO THIS SECTION 4. 
 5. Tenant Representations and Warranties; Lien Waiver. 

(a) Tenant hereby represents and warrants for purposes of this Agreement only that the following statements are true as of the date hereof:

 (i) Tenant holds the entire interest of the “tenant” under the Lease. 

(ii) Tenant has not pledged its interest in the Lease as collateral or otherwise sold, transferred, assigned or subleased all or any portion
of the Lease or the Premises. 
 (iii) Tenant has no knowledge of any claim, injury or cause of action which has occurred, whether or not
filed, by or for any party, relating to the Lease. 
 (iv) There are no contracts for the furnishing of any labor or materials remaining
unpaid and an encumbrance on the Lease with respect to improvements or alterations in or about the Premises, including, without limitation, any sums due to Balfour Beatty Construction. 

(v) No concessions or other rights of use and occupancy of the Premises have been granted by Tenant. 

(b) Tenant agrees to defend, indemnify and save Landlord harmless from and against all loss or damage sustained by Landlord (and all expenses,
costs and reasonable attorneys’ fees of Landlord in any action or defense undertaken by Landlord to protect itself from such loss or damage) resulting only from any breach by Tenant of the representations and warranties made in
Section 5(a) above. 
 (c) Tenant shall provide to Landlord, prior to the Termination Date (and as a condition to the release of Tenant
hereunder), a final waiver and release (the “Balfour Waiver”), executed by an authorized officer of Balfour Beatty Construction (“Balfour”), wherein Balfour confirms that Tenant has paid all sums due to it by Tenant and has no
claims against Landlord whatsoever. 
 6. Broker Commissions. Tenant shall provide to Landlord, prior to the Termination Date
(and as a condition to the release of Tenant hereunder), a waiver and release (the “Broker Waiver”), executed by an authorized officer of Cox Oddo Commercial (aka Dan Cox Company) (“Tenant’s Broker”), wherein Tenant’s
Broker releases Landlord of any and all obligations it may have to pay any additional sums to Tenant’s Broker pursuant to the Lease or the written agreement between Landlord and Tenant’s Broker. Further, Tenant shall indemnify and hold
Landlord harmless from all liabilities arising from any compensation claimed by any broker or agent employed by Tenant or claiming to have been engaged by Tenant. 

 7. Release. 

(a) Tenant, on its own behalf and on behalf of each of its shareholders, officers, subsidiaries, managers, board members, employees, partners,
affiliates, agents and attorneys (collectively, “Tenant Parties”) hereby release, disclaim and discharge Landlord and its officers, directors, members, partners, affiliates, subsidiaries, employees, agents and attorneys (collectively,
“Landlord Parties”) from, and covenant not to sue the Landlord Parties on account of, any and all claims that the Tenant Parties have, had or may have against the Landlord Parties including, without limitation, claims in any way relating
to the Lease, the Premises, the Building, the Project or the negotiations leading to the execution of this Agreement from the beginning of the world to the date hereof, provided, however, nothing in this Section 7(a) shall be deemed to release
Landlord from its obligations under this Agreement. 
 (b) Upon Landlord’s receipt of a signed copy of this Agreement and payment of
the Settlement Amount, Landlord shall be deemed to have released, disclaimed and discharged Tenant from, and covenanted not to sue the Tenant on account of, any and all claims that the Landlord has, had or may have against the Tenant in any way
relating to the Lease, the Premises, the Building, the Project or the negotiations leading to the execution of this Agreement from the beginning of the world to the date hereof, provided, however, nothing in this Section 7(b) shall release
Tenant from its obligations under this Agreement or from third party and environmental indemnity obligations which survive termination of the Lease. Further, the release provided herein is expressly contingent upon each of the following conditions:
(i) Tenant shall not have filed or suffered a bankruptcy or similar petition under the United States Bankruptcy Code (the “Code”) or similar state code or have made an assignment for the benefit of creditors or requested or be subject
to the appointment of a receiver for ninety-one days post Landlord’s receipt of the Settlement Amount and (ii) neither this Agreement, nor any payment or transfer contemplated hereby, shall be claimed to be or deemed by a court as a
“fraudulent conveyance” or “preference” as those terms are commonly understood under the Code or any like state statute. In furtherance of the foregoing, and not in limitation thereof, if any of the conditions set forth in the
immediately preceding sentence are not satisfied, Landlord shall be entitled to enforce all rights and or remedies under the Lease and shall not be bound by the conditional agreement to release set forth herein. 

 8. No Credit. Tenant acknowledges that it shall receive no credit against the
Settlement Amount in the event Landlord re-lets the Premises and collects rent from any successor tenant. 
 9. Further
Assurances. Landlord and Tenant shall execute such other and further agreements or instruments necessary or appropriate in order to carry out the terms of this Agreement. 

10. Confidentiality. Landlord and Tenant agree to treat the terms and existence of this Agreement as confidential, and shall not
disclose this Agreement, or the terms thereof, to any third party (other than outside counsel, auditors or insurers for Tenant or as may be required by law) absent a court order, the written consent of the non-disclosing party, or as may be required
under applicable law (including disclosures required by applicable securities laws). 
 11. Miscellaneous. 

(a) This Agreement and the provisions contained herein shall be governed and construed in accordance with the laws of the State of Texas. 

(b) The party executing this Agreement on behalf of Landlord and Tenant warrant that he/she he is duly authorized to so act. 

(c) This Agreement shall be binding upon and shall inure to the benefit of the parties hereto and their respective successors and assigns.

 (d) Unless the context otherwise specifies or requires, all the terms used in this Agreement shall have the meaning specified in the
Lease, such definitions to be applicable equally to the singular and plural forms of such terms and to all genders. 
 (e) This Agreement
may be executed in multiple counterparts and each such counterpart shall be an original and all counterparts, together, shall be a single document. The parties agree to accept and rely on facsimile or “pdf” copies of signatures on this
Agreement as originals. 
 (f) Landlord and Tenant shall execute such other and further agreements or instruments necessary or appropriate
in order to carry out this Agreement. 
 12. Amendments to Lease. Notwithstanding any termination of this Agreement due to
Landlord’s failure to execute a lease with ARM before the Contingency Date, as it may be extended, Landlord agrees as follows: 

 (a) Tenant’s failure to occupy the Premises does not constitute a default (nor, upon notice
from Landlord, an Event of Default) under the Lease. As of the date of this Agreement, Tenant is not in default under the Lease and the Lease is in full force and effect. 

(b) Landlord agrees that the date on which any undisbursed portion of the Improvement Allowance is waived, is extended from the 18-month
anniversary of the date on which the Lease is fully executed and delivered to the 24-month anniversary of the date on which the Lease was fully executed and delivered. 

Signature page to follow 

 IN WITNESS WHEREOF, Landlord and Tenant have signed and dated this Lease Termination Agreement and Release
as of the day and year first above written. 
 LANDLORD: 

G&I VII ENCINO TRACE II LP 
 By:
G&I VII Encino Trace GP LLC, its general partner 
 By: G&I VII Austin Office LLC, its sole member 

By: BDN Austin Properties LLC, its operating manager 

By: /s/ William D. Redd 

Name: William D. Redd 

Title: Executive Vice President and Senior Managing Director 

TENANT: 
 MIRNA THERAPEUTICS, INC. 

By: /s/ Alan Fuhrman 
 Name: Alan Fuhrman

 Title: Chief Financial OfficerEX-10.3(B)

 Exhibit 10.3(B) 
  

			
	Grant ID: RP101219	  	
	Attachment F - Contract Amendment	  	

  
 

 
 As indicated by the signatures below, the INSTITUTE and the RECIPIENT agree to the following amendments to the CPRIT
Contract: 
 Contract Document F: This Attachment (this “Attachment”), dated as of May 11, 2017, is hereby incorporated into and
made a part of that certain CANCER RESEARCH GRANT CONTRACT (“Contract”) effective as of August 1, 2010 by and between the Cancer Prevention and Research Institute of Texas (“CPRIT” or the “INSTITUTE”) and Mirna
Therapeutics, Inc. (the “RECIPIENT”). A capitalized term used in this Attachment shall have the meaning given the term in the Contract or in the Attachments to the Contract, unless otherwise defined herein. In the event of a conflict
between the provisions of this Attachment and the provisions of the Contract, this Attachment shall control. 1. Consistent with Texas Administrative Code, Title 25, Part 11, 703.13, and because no Grant funds were expended during the
RECIPIENT’s fiscal year in which the Contract was terminated, Section 4.01 is hereby restated and amended in its entirety as follows: Section 4.01 Record Keeping. The RECIPIENT, each Collaborator and each Contractor whose costs are
funded in all or in part by the Grant shall maintain or cause to be maintained books, records, documents and other evidence (electronic or otherwise) pertaining in any way to its performance under and compliance with the terms and conditions of this
Contract (“Records”). The RECIPIENT, each Collaborator and each Contractor shall use, or shall cause the entity which is maintaining such Records to use generally accepted accounting principles in the maintenance of such Records, and shall
retain or require to be retained all of such Records for a period of three (3) years from the Termination Date of the Contract. 2. Consistent with Texas Administrative Code, Title 25, Part 11, 703.13, and because no Grant funds were expended
during the RECIPIENT’s fiscal year in which the Contract was terminated, Section 4.02 is hereby restated and amended in its entirety as follows: Section 4.02 Audits. Upon request and with reasonable notice, the RECIPIENT, each
Collaborator and each Contractor whose costs are charged to the Project shall allow, or shall cause the entity which is maintaining such items to allow, the INSTITUTE, or auditors working on behalf of the INSTITUTE, including the State Auditor
and/or the Comptroller of Public Accounts for the State of Texas, to review, inspect, audit, copy or abstract all of its Records during regular working hours. Acceptance of funds directly under the Contract or indirectly through a subcontract under
the Contract constitutes acceptance of the authority of the INSTITUTE, or auditors working on behalf of the INSTITUTE, including the State Auditor and/or the Comptroller of Public Accounts, to conduct an audit or investigation in connection with
those funds for a period of three (3) years from the Termination Date of the Contract. Notwithstanding the foregoing, any RECIPIENT expending $500,000 or more in federal or state awards during its fiscal year shall obtain either an annual
single audit or a program specific audit. A RECIPIENT expending funds from only one federal program (as listed in the Catalog of Federal Domestic Assistance (CFDA)) or one state program may elect to obtain a program specific audit in accordance with
Office of Management and Budget (OMB) Circular A-133 or with the State of Texas Uniform Grant Management Standards (UGMS). A single audit is required if funds from more than one federal or state program are
spent by the RECIPIENT. The audited time period is the RECIPIENT’s fiscal year, not the INSTITUTE funding period. 3. Section 4.07 is revised by adding the following paragraph to the end of Section 4.07: “Following good faith
negotiations, INSTITUTE and RECIPIENT agree that in light of special circumstances, RECIPIENT shall repay the INSTITUTE $5,000,000.00 of Grant proceeds (the “Payment”) within 5 business days following the date of this Attachment and
INSTITUTE and RECIPIENT agree to the immediate and automatic termination of Section 4.07 immediately upon the Payment by RECIPIENT. INSTITUTE and RECIPIENT agree that as of the date of this Attachment, RECIPIENT has fulfilled all obligations to
INSTITUTE under Section 4.07 as 

  
 Page 1 of 2 

			
	Grant ID: RP101219	  	
	Attachment F - Contract Amendment	  	

 of such date and has no liability, obligations, or any other commitments to INSTITUTE under Section 4.07.” 4. INSTITUTE
and RECIPIENT agree to incorporate herein by reference the letter dated May 11, 2017 Re: Agreement and Resolution of Negotiations regarding Cancer Research Grant Contracts by and between the Cancer Prevention and Research Institute of Texas and
Mirna Therapeutics, Inc., as uploaded into CGMS Ad Hoc Documents May 11, 2017 to this Attachment F-4. 

Description: To amend Section 4.01 Record Keeping, Section 4.02 Audits and Section 4.07 of the Contract. Incorporate by reference the
letter dated May 11, 2017 Re: Agreement and Resolution of Negotiations regarding Cancer Research Grant Contracts by and between the Cancer Prevention and Research Institute of Texas and Mirna Therapeutics, Inc., as uploaded into CGMS Ad Hoc
Documents May 11, 2017 to this Attachment F-4. 
  

					
	RECIPIENT	 		  	INSTITUTE
	Mirna Therapeutics, Inc.	 		  	Cancer Prevention & Research
	ASO Name: DeYoung, Casi	 		  	Institute of Texas
	Submitted Date: 11 May 2017	 		  	CEO Name: Roberts, Wayne
		 		  	Approved Date: 11 May 2017

  
 Page 2 of 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}]]